Results

Bluewillow Biologics Inc

04/15/2023 | Press release | Archived content

Dr. Shabaana Khader, University of Chicago, highlights promise of intranasal mucosal vaccine strategy for tuberculosis.

Bluewillow Biologics Inc published this content on April 15, 2023, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 02, 2026 at 07:11 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]